Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138994 · ClinicalTrials.gov registry record · NA
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
A NA study, sponsored by Next Science TM.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT02138994 is a NA study that has completed, run by Next Science TM. The registered enrollment target is 43 participants.
The verdict
NCT02138994, a NA study, has completed, sponsored by Next Science TM.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a 3 to 4 months, multi-site, prospective randomized clinical study of patients diagnosed with a chronic wound. The primary objective is to assess changes in healing rate, by measuring differences in wound area when treating chronic wounds with the Next Science Wound Gel compared to the Triple Antibiotic Ointment Neosporin (Standard of Care, SOC). At the end of the study period, patients may continue receiving their assigned study treatment provided they have signed the "Continuation of Treatment Informed Consent" and the rational for continuation is documented by the investigator.
Interventions
- DEVICE Next Science Wound Gel
- DRUG Triple Antibiotic Ointment Neosporin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02138994
The ClinicalTrials.gov registry entry for NCT02138994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Next Science TM, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Next Science Wound Gel is the first listed.
NCT02138994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02138994 about?
NCT02138994 is a clinical study titled "Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care". This is a 3 to 4 months, multi-site, prospective randomized clinical study of patients diagnosed with a chronic wound. The primary objective is to assess changes in healing rate, by measuring differences in wound area when treating chronic wounds with the Next Science Wound Gel compared to the Tripl...
What is the current status of trial NCT02138994?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-07. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02138994?
The interventions under investigation include: Next Science Wound Gel (DEVICE), Triple Antibiotic Ointment Neosporin (DRUG).
Who is sponsoring clinical trial NCT02138994?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.